Prostate cancer
Open
Phase 3
This study is looking at using apalutamide to slow down the growth of prostate cancer.
It is open to men whose early prostate cancer is being managed by active surveillance. And who have a higher risk of their cancer getting worse.
Recruitment start: 24 April 2023
Recruitment end: 31 January 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Vincent Gnanapragasam
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge
Last reviewed: 10 July 2025
CRUK internal database number: 18021
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
